We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Environmental Nanoplastic Accumulation and Neurodegenerative Disease in Animal Models
AI summary Read the abstract
This review examines animal model evidence linking environmental nanoplastic accumulation in brain tissue to neurodegeneration, synthesizing studies showing that nanoplastics trigger neuroinflammation, protein aggregation, and synaptic dysfunction relevant to Parkinson's and Alzheimer's disease pathology.
It is well known that production of plastic and deposition of waste worldwide are constantly increasing and microplastic contaminants in water and food supplies have been reported. Microplastics are commonly defined as particles with a diameter smaller than 5 mm but also include smaller nanoplastics particles of less than 1 μm size. Disposable polystyrene products, including packing materials, cups and cutlery, are the main objects accumulating in the environment that contribute to plastic pollution. As a consequence, small plastic particles are found in marine environments and presumably they derive from ultraviolet radiation exposures and plastic erosion. Experimental studies report that polystyrene nanoplastics can enter organisms inducing modification of tissue structure and function, such as endothelial leakiness and potentially compromise the blood-brain barrier in mammals.1 Parkinson’s disease (PD) is a neurodegenerative disease characterized by progressive degeneration of a rather selective neuronal population located in the ventral midbrain that provides dopaminergic innervation within basal ganglia circuitry that controls voluntary movement. In PD, progressive loss of dopaminergic neurons (DAn) causes low dopamine (DA) levels in the brain and the appearance of resting tremor, bradykinesia and rigidity, cardinal motor symptoms of PD. Abnormal accumulation α-synuclein (α-syn) in Lewy bodies and Lewy neurites is an important characteristic of the neurodegenerative processes of substantia nigra pars compacta (SNpc) DAn neurons in Parkinson's disease (PD) and other synucleinopathies.2,3 Animal models of PD display such accumulation of α-syn in the mesencephalic area, striatum and frontal cortex, accompanied to severe dysfunctions in the dorsolateral striatum. α-syn is a low-molecular weight protein, but in PD-affected tissues, it forms fibril structures that interact with damaged lipids deriving from various organelles, such as lysosomes and mitochondria.4 We will discuss recent literature on the role that specific types of nanoparticles, that are increasing in the environment, have in promoting α-syn aggregation and fibril elongation in neurons. We will also discuss the importance of model systems related to α-syn pathobiology to further explore different types of nanoparticles as potential toxins in PD. References 1. W.Wei, Y.Li, M.Lee, N.Andrikopoulos, S.Lin, C.Chen, D.T.Leong, F.Ding, Y.Song, P.C.Ke, Anionic nanoplastic exposure induces endothelial leakiness. Nat. Commun. 13,4757(2022).2. Braak H, Del Tredici K, Rub U, De Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003;24:197–211.3. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 1997;276:2045–2047.4. D. Erskine, D. Koss, V.I. Korolchuk,T.F. Outeiro, J. Attems, I. McKeith, Lipids, lysosomes and mitochondria: Insights into Lewy body formation from rare monogenic disorders. Acta Neuropathol. 141, 511–526(2021).
More Papers Like This
Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities
AI summary Read the abstract
Researchers review how microplastics and nanoplastics may reach the brain via inhalation and systemic routes, proposing that chronic neuroinflammation, oxidative stress, and direct interactions with proteins like amyloid-β and α-synuclein could link particle exposure to Alzheimer's, Parkinson's, and other neurodegenerative conditions.
Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities
AI summary Read the abstract
Researchers reviewed emerging evidence that micro- and nanoplastics may contribute to neurodegeneration by promoting neuroinflammation, oxidative stress, blood-brain barrier disruption, and direct interactions with aggregation-prone proteins like amyloid-β and α-synuclein, proposing that pre-existing neurological disease may increase susceptibility to particulate accumulation in brain tissue.
The role of microplastics exposure in Alzheimer’s and Parkinson’s disease
AI summary Read the abstract
Researchers reviewed the mechanistic links between microplastic and nanoplastic exposure and the two most common neurodegenerative diseases — Alzheimer's and Parkinson's — finding evidence that oxidative stress, neuroinflammation, blood-brain barrier disruption, and protein aggregation are key pathways connecting plastic pollution to neurodegeneration.
From the Environment to Molecular Interactions of Nanoplastics: Unraveling the Neurotoxic Impacts and the Implications in Neurodegenerative Processes
AI summary Read the abstract
This review examines how nanoplastics can cross the blood-brain barrier and potentially contribute to brain damage and neurodegenerative diseases like Alzheimer's and Parkinson's. Nanoplastics have been found in food, water, and air, and once they reach the brain they can trigger inflammation, oxidative stress, and protein misfolding. The review calls for more realistic lab studies and better detection methods to understand the true scope of nanoplastic effects on brain health.
Microplastics and nanoplastics in neurodegenerative disease: A scoping review
AI summary Read the abstract
This review of animal and human studies finds that tiny plastic particles may build up in the brain and are linked, in lab animals, to damage resembling Alzheimer's and Parkinson's disease. However, most studies used one lab-made plastic type, not real-world mixtures, so scientists can't yet say microplastics actually cause these diseases in people.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.